Previously overlooked proteins are a potential source for a new class of cancer killing drugs

OICR-supported collaboration discovers new method to stunt the growth of brain cancers

New advances towards targeted therapies for triple negative breast cancer

Op-ed in The Globe and Mail hails innovation strategy that resulted in record-breaking investment by Celgene

Can an open drug discovery model find a solution for rare brain cancers in children?

OICR launches groundbreaking Cancer Therapeutics Innovation Pipeline to drive cutting-edge therapies to the clinic

Open source cancer research

The Ontario Institute for Cancer Research and the Structural Genomics Consortium develop and give away new drug-like molecule to help crowd-source cancer research